Acinetobacter baumannii complex: Difference between revisions
From IDWiki
Acinetobacter baumannii complex
m (Text replacement - "[[Has Gram stain::" to "[[Stain::") |
No edit summary |
||
Line 1: | Line 1: | ||
+ | == Background == |
||
⚫ | |||
⚫ | |||
+ | === Microbiology === |
||
+ | |||
⚫ | |||
⚫ | |||
+ | |||
+ | == Management == |
||
+ | |||
+ | * Choice of antibiotic depends on susceptibility testing |
||
+ | * Possible options include: |
||
+ | ** [[Cefepime]], [[ceftriaxone]], and [[cefotaxime]] |
||
+ | ** [[Cefiderocol]] |
||
+ | ** [[Carbapenems]] |
||
+ | ** [[Tigecycline]] |
||
+ | ** [[Colistin]] and [[polymyxin B]] (though [[Acinetobacter junii]] has inherent resistance) |
||
+ | * [[Aminoglycosides]] may not penetrate well into lungs and brain, so are usually avoided |
||
+ | * [[Bacteriophages]] are promising |
||
{{DISPLAYTITLE:''Acinetobacter baumannii'' complex}} |
{{DISPLAYTITLE:''Acinetobacter baumannii'' complex}} |
||
[[Category:Gram-negative bacilli]] |
[[Category:Gram-negative bacilli]] |
Revision as of 18:48, 28 August 2020
Background
Microbiology
- Contains Acinetobacter baumannii, Acinetobacter nosocomialis, and Acinetobacter pittii
- Non-motile, non-fermenting Gram-negative bacillus
Management
- Choice of antibiotic depends on susceptibility testing
- Possible options include:
- Cefepime, ceftriaxone, and cefotaxime
- Cefiderocol
- Carbapenems
- Tigecycline
- Colistin and polymyxin B (though Acinetobacter junii has inherent resistance)
- Aminoglycosides may not penetrate well into lungs and brain, so are usually avoided
- Bacteriophages are promising